|
30 Jan 2007 |
GlaxoSmithKline files its new pre-pandemic influenza vaccine in Europe
|
|
30 Jan 2007 |
Par Pharmaceutical Receives Approval Of Generic Inderal-LA(R)
|
|
30 Jan 2007 |
Aurobindo bags one more cephalosporin from USFDA
|
|
30 Jan 2007 |
OccuLogix's RHEO-AMD Trial Protocol Cleared by the FDA
|
|
26 Jan 2007 |
Biocryst Initiates Phase II Influenza Clinical Trial To Evaluate Peramivir
|
|
26 Jan 2007 |
Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch
|
|
26 Jan 2007 |
BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS®1 to Treat Distal Radius Fractures
|
|
26 Jan 2007 |
BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS®1 to Treat Distal Radius Fractures
|
|
25 Jan 2007 |
Kirin and Astellas Enter Into a Licensing Agreement on an Immunosuppressive Fully Human Monoclonal Antibody
|
|
25 Jan 2007 |
Scil Technology Completes Patient Enrollment in European Phase II Sinus Lift Study
|
|
25 Jan 2007 |
Scil Technology Completes Patient Enrollment in European Phase II Sinus Lift Study
|
|
25 Jan 2007 |
MediVas Announces Signing of Collaboration Agreement with Pfizer
|
|
25 Jan 2007 |
MediVas Announces Signing of Collaboration Agreement with Pfizer
|
|
25 Jan 2007 |
Foamix Signs R&D Collaboration And License Agreement With Dr. Reddy's Laboratories, Inc's For The Development And Commercialization Of Psoriasis Foam
|
|
24 Jan 2007 |
Medarex and Compugen Announce Therapeutic Antibody Co-Development Agreement
|
|
24 Jan 2007 |
Barr Pharmaceuticals, Inc.'s Subsidiary Pliva D.D. Receives Approval For Generic ZITHROMAX(R) IV, 500 mg Vial
|
|
23 Jan 2007 |
Halozyme Therapeutics Releases Results of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Protein Molecule Therapeutic
|
|
23 Jan 2007 |
Innocoll Receives FDA Approval to Commence a Phase 2 Clinical Trial for the Topical Treatment of Infected Diabetic Foot Ulcers With its CollaRx(R) GENTAMICIN
|
|
23 Jan 2007 |
Innocoll Receives FDA Approval to Commence a Phase 2 Clinical Trial for the Topical Treatment of Infected Diabetic Foot Ulcers With its CollaRx(R) GENTAMICIN
|
|
23 Jan 2007 |
Wockhardt signs in-licensing pact with Crawford Healthcare of UK, Launches Vitix for vitiligo skin disorder
|
|
23 Jan 2007 |
Shire licenses the North American rights for SPD754 (apricitabine) to Avexa Ltd
|
|
23 Jan 2007 |
Hikma expands into the oncology market
|
|
20 Jan 2007 |
Penwest Begins Next Study in Development of Nalbuphine ER
|
|
20 Jan 2007 |
Bayer Schering Pharma to develop new imaging compounds for detection of Neurodegenerative Diseases
|
|
19 Jan 2007 |
Alexza Completes Enrollment in AZ-004 Phase IIa Clinical Trial in Schizophrenic Patients with Acute Agitation
|
